Suzlon surges 7% on buzz of investment from Sun Pharma's Shanghvi family
As per reports, Dilip Shanghvi will provide as much as Rs 38 billion ($610 million) of security for Suzlon Energy Ltd to help the maker of wind turbines fill orders and return to profit.

Mumbai: Shares of Suzlon Energy today surged over 7 percent amid reports that Sun Pharma's Dilip Shanghvi will provide as much as Rs 3,800 crore of security that will help the wind turbine maker in availing credits.[caption id="attachment_2060833" align="alignleft" width="380"]
Energizing wind power. Reuters[/caption]Following the buzz, shares of Suzlon jumped 7.32 percent to Rs 27.10 on the BSE.On the NSE, it climbed 7.32 percent to Rs 27.10.. Dilip Shanghvi is the founder and managing director of Sun Pharmaceuticals.As per reports, Dilip Shanghvi will provide as much as Rs 38 billion ($610 million) of security for Suzlon Energy Ltd to help the maker of wind turbines fill orders and return to profit. The security from the Shanghvi family will make it easier for Suzlon to obtain more bank guarantees and letters of credit to ramp up its business, it said.Meanwhile, earlier this month, Suzlon signed definitive pacts with DSA for equity investment of Rs 1,800 crore in the company, amounting to 23 percent stake.DSA also announced an open offer to acquire 26 percent stake in Suzlon at Rs 18 per share aggregating to Rs 2,837 crore. PTI

Google burns cash for first time as AI spending pushes 2026 capex to $205 billion
Tesla sells more cars but makes less money: Why Musk’s AI pivot is squeezing profits
No premium queues, 30-minute target: What changes for Indian passport applicants in UAE
Bharat Forge, Flying Whales sign pact to develop 60-tonne airships for India’s defence logistics
Air India to cut Delhi-Toronto flight time by 3 hours, resume non-stop services from August 1

